Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. The Company's innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. The company believes that Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA registered, exempt Class I or Class 2 devices for the treatment of hearing loss. The Company's differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States. The company’s 4th generation product, the Eargo Neo HiFi, was launched in January 2020 and features improved capabilities across audio fidelity and bandwidth.
Company profile
Ticker
EAR
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Avanos Medical • Edwards Lifesciences • Invacare • MSA Safety • Align Technology • Surgalign ...
SEC CIK
Corporate docs
Subsidiaries
Eargo Hearing, Inc. • Eargo Screening, LLC ...
IRS number
273879804
EAR stock data
Latest filings (excl ownership)
8-K
Material Modifications to Rights of Security Holders
17 Jan 23
8-K
Entry into a Material Definitive Agreement
13 Jan 23
8-K
Eargo to Complete a 1-for-20 Reverse Stock Split
11 Jan 23
8-K
Hearing Wellness Pioneer Eargo Launches
4 Jan 23
S-1
IPO registration
16 Dec 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Dec 22
8-K/A
Eargo Announces Closing of Rights Offering and Conversion of Patient Square Notes into Shares of Eargo Common Stock
12 Dec 22
8-K
Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder
7 Dec 22
8-K
Eargo Announces Closing of Rights Offering and Conversion of Patient Square Notes into Shares of Eargo Common Stock
29 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Nov 22
Latest ownership filings
SC 13G/A
BlackRock Inc.
6 Jan 23
SC 13D/A
Nan Fung Group Holdings Ltd
16 Dec 22
SC 13D/A
New Enterprise Associates 15, L.P.
12 Dec 22
4
Donald J Spence
9 Dec 22
4
Onkarr Narula
9 Dec 22
4
Afshin Justin Sabet-Peyman
9 Dec 22
4
Trit Garg
9 Dec 22
3
Afshin Justin Sabet-Peyman
9 Dec 22
3
Trit Garg
9 Dec 22
3
Onkarr Narula
9 Dec 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 88.08 mm | 88.08 mm | 88.08 mm | 88.08 mm | 88.08 mm | 88.08 mm |
Cash burn (monthly) | 6.19 mm | 5.70 mm | 16.88 mm | 13.27 mm | 4.66 mm | 11.82 mm |
Cash used (since last report) | 24.12 mm | 22.22 mm | 65.82 mm | 51.75 mm | 18.18 mm | 46.10 mm |
Cash remaining | 63.95 mm | 65.85 mm | 22.25 mm | 36.33 mm | 69.90 mm | 41.98 mm |
Runway (months of cash) | 10.3 | 11.6 | 1.3 | 2.7 | 15.0 | 3.6 |
Institutional ownership, Q3 2022
60.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 50 |
Opened positions | 9 |
Closed positions | 24 |
Increased positions | 13 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 447.42 mm |
Total shares | 23.82 mm |
Total puts | 764.30 k |
Total calls | 315.60 k |
Total put/call ratio | 2.4 |
Largest owners | Shares | Value |
---|---|---|
NEA Management | 4.52 mm | $4.75 mm |
New Enterprise Associates 15 | 4.52 mm | $150.07 mm |
Gilde Healthcare Holding B.V. | 3.31 mm | $180.06 mm |
Nan Fung | 2.89 mm | $3.03 mm |
Alger Associates | 1.96 mm | $39.15 mm |
Longitude Capital Partners IV | 1.92 mm | $64.33 mm |
Renaissance Technologies | 1.05 mm | $1.11 mm |
Oasis Management | 711.39 k | $747.00 k |
BLK Blackrock | 602.98 k | $633.00 k |
Vanguard | 406.50 k | $427.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Dec 22 | Spence Donald J | Stock Options Common Stock | Grant | Acquire A | No | No | 0.73 | 117,194 | 85.55 k | 117,194 |
News
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
23 Jan 23
Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday
23 Jan 23
Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
23 Jan 23
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
13 Dec 22
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
13 Dec 22
Press releases
Eargo Effects 1-for-20 Reverse Stock Split
17 Jan 23
Hearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CES
4 Jan 23
Eargo and NationsBenefits Announce Strategic Partnership
12 Dec 22
NationsBenefits and Eargo Announce Partnership to Offer Over-the-Counter Hearing Aids
12 Dec 22
CapitalGainsReport Sector Spotlight: Medical Device Stocks (WHSI, BHC, GMVD, EAR)
12 Dec 22